Tumour Infiltrating Lymphocyte (TIL) Therapy hubs for Melanoma (Adults)

Description

NHS Arden and Greater East Midlands Commissioning Support Unit (AGCSU), on behalf of NHS England Specialised Commissioning (referred to as the Authority) is inviting suitably qualified and experienced providers to express interest in the provision of Tumour Infiltrating Lymphocyte (TIL) Therapy hubs for Melanoma (Adults) by responding to this accreditation process. As a result of this procurement exercise an agreement will be established with the successful bidder(s) for a period of five (5) years with the Commissioners having the option to extend for up to an additional four (4) year(s) (maximum contract duration nine (9) years). The deadline for submissions is12.00pm (noon) on Monday 13th October 2025.